Revaprazan, a novel acid pump antagonist, exerts anti-inflammatory action against Helicobacter pylori-induced COX-2 expression by inactivating Akt signaling

Journal of Clinical Biochemistry and Nutrition

Volumn 51, Issue 2, 2012, Pages 77-83

  Lee, Jeong Sang ^a   Cho, Ji Yoon ^b   Song, Heup ^a   Kim, Eun Hee ^a   Hahm, Ki Baik ^a  

^a Gachon University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Akt; Anti inflammatory effects; Helicobactor pylori; NF B; Revaprazan

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; I KAPPA B ALPHA; PROTEIN KINASE B; REVAPRAZAN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME INACTIVATION; ENZYME INDUCTION; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; HYPOTHESIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

HELICOBACTER PYLORI;

EID: 84865963737     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-94     Document Type: Article

References (29)

1. Saukkonen K, Rintahaka J, Sivula A, et al. Cyclooxygenase-2 and gastric carcinogenesis. APMIS 2003; 111: 915-925. (Pubitemid 37352608)
2. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994; 10: 405-455.
3. Guo YS, Hellmich MR, Wen XD, Townsend CM, Jr. Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells. J Biol Chem 2001; 276: 22941-22947.
4. Keates S, Hitti YS, Upton M, Kelly CP. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology 1997; 113: 1099-1109. (Pubitemid 27418963)
5. Xie J, Qian J, Wang S, Freeman ME, 3rd, Epstein J, Yi Q. Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38. J Immunol 2003; 171: 4792-4800. (Pubitemid 37310599)
6. Romashkova JA, Makarov SS. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999; 401: 86-90.
7. Van Dross, Hong X, Pelling JC. Inhibition of TPA-induced cyclooxygenase-2 (COX-2) expression by apigenin through downregulation of Akt signal transduction in human keratinocytes. Mol Carcinog 2005; 44: 83-91. (Pubitemid 41397173)
8. Takagi T, Naito Y, Okada H, et al. Lansoprazole, a proton pump inhibitor, mediates anti-inflammatory effect in gastric mucosal cells through the induction of heme oxygenase-1 via activation of NF-E2-related factor 2 and oxidation of kelch-like ECH-associating protein 1. J Pharmacol Exp Ther 2009; 331: 255-264.
9. Yeo M, Kim DK, Kim YB, et al. Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells. Clin Cancer Res 2004; 10: 8687-8696. (Pubitemid 40053438)
10. Yeo M, Kwak MS, Kim DK, et al. The novel acid pump antagonists for anti-secretory actions with their peculiar application beyond acid suppression. J Clin Biochem Nutr 2006; 38: 1-8.
11. Ock CY, Lim YJ, Kim YJ, et al. Acid pump antagonist-provoked HSP27 dephosphorylation and accentuation rescues stomach from indomethacin-induced damages. J Dig Dis 2011; 12: 71-81.
12. Park S, Han SU, Lee KM, Park KH, Cho SW, Hahm KB. 5-LOX inhibitor modulates the inflammatory responses provoked by Helicobacter pylori infection. Helicobacter 2007; 12: 49-58. (Pubitemid 46105919)
13. Lee KM, Hwang MK, Lee DE, Lee KW, Lee HJ. Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells. J Agric Food Chem 2010; 58: 5815-5820.
14. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-780.
15. Surh YJ, Chun KS, Cha HH, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: downregulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat Res 2001; 480-481: 243-268.
16. D'Acquisto F, Iuvone T, Rombolà L, Sautebin L, Di Rosa, Carnuccio R. Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett 1997; 418: 175-178. (Pubitemid 27514441)
17. Sawaoka H, Kawano S, Tsuji S, et al. Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostaglandins Leukot Essent Fatty Acids 1998; 59: 313-316. (Pubitemid 29017346)
18. Kim H, Lim JW, Kim KH. Helicobacter pylori-induced expression of interleukin-8 and cyclooxygenase-2 in AGS gastric epithelial cells: mediation by nuclear factor-kappaB. Scand J Gastroenterol 2001; 36: 706-716. (Pubitemid 32568548)
19. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996; 87: 13-20.
20. Chu SH, Kim H, Seo JY, Lim JW, Mukaida N, Kim KH. Role of NF-kappaB and AP-1 on Helicobacter pylori-induced IL-8 expression in AGS cells. Dig Dis Sci 2003; 48: 257-265. (Pubitemid 36232989)
21. Abdel-Latif MM, Windle H, Terres A, Eidhin DN, Kelleher D, Reynolds JV. Helicobacter pylori extract induces nuclear factor-kappa B, activator protein-1, and cyclooxygenase-2 in esophageal epithelial cells. J Gastrointest Surg 2006; 10: 551-562. (Pubitemid 43619149)
22. Chang F, Lee JT, Navolanic PM, et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 2003; 17: 590-603. (Pubitemid 36395654)
23. Béraud C, Henzel WJ, Baeuerle PA. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation. Proc Natl Acad Sci USA 1999; 96: 429-434.
24. Allen LA, Allgood JA, Han X, Wittine LM. Phosphoinositide3-kinase regulates actin polymerization during delayed phagocytosis of Helicobacter pylori. J Leukoc Biol 2005; 78: 220-230. (Pubitemid 40979961)
25. Kane LP, Shapiro VS, Stokoe D, Weiss A. Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol 1999; 9: 601-604.
26. Figura N, Armellini D, Bugnoli M, Bayeli PF, Gennari C, Crabtree JE. Activity of omeprazole on Helicobacter pylori and relation to toxicity of strains. J Clin Pathol 1994; 47: 440-442. (Pubitemid 24183931)
27. Mauch F, Bode G, Malfertheiner P. Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors. Am J Gastroenterol 1993; 88: 1801-1802. (Pubitemid 23298143)
28. Lage AP, Glpczynski Y. Omeprazole exerts the same inhibitory effect on the growth of cytotoxic-positive and cytotoxic-negative Helicobacter pylori strains and does not inhibit vacuolating toxin production. Eur J Gastroenterol Hepatol 1994; 6: 299-301. (Pubitemid 24103682)
29. Kim JH, Kim EH, Ock C, et al. Mitigating endoplasmic reticulum stress with revaprazan ameliorates stress-related mucosal disease. J Gastroenterol Hepatol 2012; 27(1): 120-129.